September 3, 2014
  • Few Pharmacists Urge Diabetes Patients to Use Control Solution 

    Very few diabetes patients regularly use control solution to check the accuracy of their glucometers, and pharmacists are not doing enough to influence them do that, according to a new study. Find out how rarely pharmacists counsel patients to use control solution and why. 

  • Prescriptions for Novel Anticoagulants Increase Rapidly—But at a Cost 

    This will come as no surprise to most pharmacists, but prescriptions for novel oral anticoagulants are rising quickly, usually in lieu of warfarin. A new survey discusses the rapid increase in use of NOACs and what that means for patient care as well as healthcare expenses.

  • When Do Depression Medications Help Enough? Here’s an Answer

    When is antidepressant medication enough to control depression and when is the addition of cognitive therapy necessary? A new study comes up with an answer to that question, noting that the key determinants are the severity and chronic nature of depression. Here are the details.

  • Aspirin Reduces VTE Risk When Other Anticoagulants Are Not Appropriate 

    No one is suggesting that aspirin should replace warfarin or novel oral anticoagulants as standard treatment for venous thromboembolism, but a new study finds that the common drug can reduce the risk of recurrence by up to 42%. Here’s why that is especially important information for treating patients who can’t or won’t use the other drugs for financial, clinical or other reasons.


U.S. Pharmacist Social Connect